100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
Trody 90mg Tablet is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to a subclass known as Selective Cyclooxygenase-2 (COX-2) Inhibitors. It is used for the relief of pain and inflammation associated with various conditions, including osteoarthritis, rheumatoid arthritis (RA), ankylosing spondylitis (AS), and acute gouty arthritis. By selectively blocking the COX-2 enzyme, Etoricoxib reduces the production of prostaglandins, which are chemicals responsible for causing pain, fever, and swelling.
Trody 90mg Tablet contains Etoricoxib, a potent, orally active, and highly selective inhibitor of the Cyclooxygenase-2 (COX-2) enzyme. NSAIDs work by blocking COX enzymes. There are two main types: COX-1 and COX-2.
COX-1 is responsible for producing prostaglandins that protect the stomach lining and aid in blood clotting.
COX-2 is responsible for producing prostaglandins in response to injury or inflammation, causing pain and swelling.
Traditional, non-selective NSAIDs block both COX-1 and COX-2, which is why they frequently cause gastrointestinal ulcers and bleeding. Etoricoxib, however, is designed to selectively target COX-2. This selectivity is intended to provide effective anti-inflammatory and pain relief benefits while minimising the severe gastrointestinal side effects associated with COX-1 inhibition.
Despite its GI benefits, the selective inhibition of COX-2 can upset the natural balance of substances that regulate blood vessel function, which is linked to its increased cardiovascular risk profile. Therefore, Etoricoxib is generally reserved for patients who need NSAIDs but are at high risk of GI complications.
Crucial Safety Note: Because Etoricoxib is a selective COX-2 inhibitor, it carries a potentially increased risk of serious cardiovascular (CV) events, including heart attack and stroke, especially with long-term use and high doses. It should be used at the lowest effective dose for the shortest possible duration.
Trody 90mg Tablet (Etoricoxib) is indicated for the symptomatic relief of pain and inflammation in adults and adolescents 16 years of age and older:
Trody 90mg Tablet is generally well-tolerated, but common and, more importantly, rare but severe side effects require immediate monitoring and action.
These are serious risks associated with NSAIDs, especially selective COX-2 inhibitors. Stop taking the medication and seek emergency help immediately if you experience any of the following:
These effects are generally mild and may decrease as your body adjusts. Consult your doctor if they persist or worsen.
Cardiovascular Risk
HIGH ALERT. Do not use if you have established ischemic heart disease (e.g., angina, previous heart attack), cerebrovascular disease (stroke), or uncontrolled high blood pressure. Stop immediately and call a doctor if you develop chest pain or sudden shortness of breath.
Gastrointestinal Risk
Use with caution if you have a history of GI ulcers or bleeding. Consider taking a protective agent (e.g., a Proton Pump Inhibitor) if prescribed by your doctor.
Pregnancy
FORBIDDEN (Especially in 3rd Trimester). Avoid use during the last trimester, as NSAIDs can harm the foetus's circulatory system (premature closure of the ductus arteriosus). Consult your doctor immediately if pregnant or planning.
Breastfeeding
CONSULT DOCTOR. Etoricoxib passes into breast milk. Use only if the benefit outweighs the risk, and monitor the infant for any adverse effects.
Alcohol
AVOID. Alcohol consumption increases the risk of stomach irritation and gastrointestinal bleeding when combined with Etoricoxib.
Driving
USE CAUTION. Some patients report dizziness or somnolence. If affected, avoid driving or operating heavy machinery.
Renal/Hepatic
DOSE ADJUSTMENT REQUIRED. Patients with severe hepatic (liver) impairment require a reduced dose (max 60mg/day). Monitor kidney function carefully, especially in the elderly or those with heart failure, as NSAIDs can impair kidney function.
Etoricoxib has several important drug interactions:
Caution is required for patients with:
The standard daily dose for Etoricoxib 90mg varies based on the condition being treated:
An overdose of Trody 90mg Tablet may result in severe GI toxicity (bleeding, perforation), acute kidney failure, and severe cardiovascular events. Other symptoms may include nausea, vomiting, stomach pain, drowsiness, and, in rare cases, respiratory depression.
If an overdose is suspected, seek emergency medical care immediately. Treatment is supportive, as there is no specific antidote.
If you miss a dose of Trody 90mg Tablet, take it as soon as you remember. However, if it is already time for your next scheduled dose, skip the missed dose and continue with your regular once-daily schedule. Do not take a double dose to make up for the missed one, as this increases the risk of side effects.
https://www.medicines.org.uk/emc/product/9317/pil
https://go.drugbank.com/drugs/DB01628
https://www.gov.uk/drug-safety-update/etoricoxib-arcoxia-revised-dose-recommendation-for-rheumatoid-arthritis-and-ankylosing-spondylitis
Therapeutic Class
Nonsteroidal Anti-inflammatory Drug (NSAID) / Anti-rheumatic
Action Class
Anti-inflammatory and Analgesic
Chemical Class
Selective Cyclooxygenase-2 (COX-2) Inhibitor
Habit Forming
No
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100

Download Now